Notice of a meeting of a working group of the NIH Blue Ribbon Panel, 61719 [2011-25733]

Download as PDF Federal Register / Vol. 76, No. 193 / Wednesday, October 5, 2011 / Notices York City, USA, Aug 30–Sept 3, 2006, pp 350–353; doi 10.1109/ IEMBS.2006.259734. 2. Hripcsak G, et al. Mining complex clinical data for patient safety research: a framework for event discovery. J Biomed Inform. 2003 Feb–Apr;36(1– 2):120–130. [PMID 14552853]. 3. Horsky J, et al. A framework for analyzing the cognitive complexity of computer assisted clinical ordering. J Biomed Inform. 2003 Feb–Apr;36(1– 2):4–22. [PMID 14552843]. Intellectual Property: HHS Reference No. E–227–2009/0—Research Tool. Patent protection is not being pursued for this technology. Licensing Contact: Michael Shmilovich, Esq.; 301–435–5019; shmilovm@mail.nih.gov. Dated: September 26, 2011. Richard U. Rodriguez, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 2011–25730 Filed 10–4–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group, Developmental Biology Subcommittee. Date: October 20–21, 2011. Time: 8:30 a.m .to 5 p.m. Agenda: To review and evaluate grant applications. Place: The River Inn, 924 25th Street, NW., Washington, DC 20037. Contact Person: Cathy J. Wedeen, PhD, Scientific Review Officer, Division of Scientific Review, OD Eunice Kennedy Shriver National Institute of Child Health VerDate Mar<15>2010 19:11 Oct 04, 2011 Jkt 226001 61719 and Human Development, NIH, 6100 Executive Blvd., Room 5B01–G, Bethesda, MD 20892, 301–435–6878, wedeenc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) neidl.od.nih.gov/. For additional information concerning this meeting, contact Ms. Kelly Fennington, Senior Health Policy Analyst, Office of Biotechnology Activities, Office of Science Policy, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892–7985; telephone 301–496– 9838; e-mail fennington@nih.gov. Dated: September 28, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Dated: September 27, 2011. Amy P. Patterson, Director, Office of Science Policy, National Institutes of Health. [FR Doc. 2011–25633 Filed 10–4–11; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2011–25733 Filed 10–4–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Notice of a meeting of a working group of the NIH Blue Ribbon Panel The purpose of this notice is to inform the public about a meeting of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories at Boston University Medical Center. The meeting will be held Wednesday, November 2, 2011, at the Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814 from approximately 8:30 a.m. to 4:30 p.m. This meeting is the fourth in a series of public meetings to review and discuss the ongoing supplementary risk assessment study being conducted for the Boston University NEIDL. The National Research Council Committee on Technical Input will participate in this discussion and provide its views. Public comment will begin at approximately 4 p.m. In the event that time does not allow for all those interested to present oral comments, anyone may file written comments by sending them to the address below. Comments should include the name, address, telephone number and when applicable, the business or professional affiliation of the commenter. The meeting will be open to the public, with attendance limited to space available. There will be a live webcast of the meeting which can be accessed at https://nihblueribbonpanel-bumcneidl.od.nih.gov/. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A draft agenda and slides for the meeting may be obtained by connecting to https://nihblueribbonpanel-bumc- PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, ‘‘Investigator Initiated Program Project Application.’’ Date: October 26, 2011. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Michelle M Timmerman, PhD, Scientific Review Officer, Scientific Review Program, NIH/NIAID/DHHS, Room 3123, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892–7616, (301) 451–4573, timmermanm@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 76, Number 193 (Wednesday, October 5, 2011)]
[Notices]
[Page 61719]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25733]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of a meeting of a working group of the NIH Blue Ribbon 
Panel

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University 
Medical Center.
    The meeting will be held Wednesday, November 2, 2011, at the Hyatt 
Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814 from 
approximately 8:30 a.m. to 4:30 p.m.
    This meeting is the fourth in a series of public meetings to review 
and discuss the ongoing supplementary risk assessment study being 
conducted for the Boston University NEIDL. The National Research 
Council Committee on Technical Input will participate in this 
discussion and provide its views.
    Public comment will begin at approximately 4 p.m. In the event that 
time does not allow for all those interested to present oral comments, 
anyone may file written comments by sending them to the address below. 
Comments should include the name, address, telephone number and when 
applicable, the business or professional affiliation of the commenter.
    The meeting will be open to the public, with attendance limited to 
space available. There will be a live webcast of the meeting which can 
be accessed at https://nihblueribbonpanel-bumc-neidl.od.nih.gov/. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    A draft agenda and slides for the meeting may be obtained by 
connecting to https://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For 
additional information concerning this meeting, contact Ms. Kelly 
Fennington, Senior Health Policy Analyst, Office of Biotechnology 
Activities, Office of Science Policy, Office of the Director, National 
Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 
20892-7985; telephone 301-496-9838; e-mail fennington@nih.gov.

    Dated: September 27, 2011.
Amy P. Patterson,
Director, Office of Science Policy, National Institutes of Health.
[FR Doc. 2011-25733 Filed 10-4-11; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.